Comparison of Low-radiation Dose CT Angiography With Invasive Coronary Angiography in Stable Coronary Disease
|Study Design:||Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
|Official Title:||Diagnostic Accuracy of New Generation Low-dose CT Coronary Angiography|
- Sensitivity and specificity [ Time Frame: 24 hours ]The results from the CT coronary angiography will be compared with the results from the conventional invasive coronary angiography which in this respect is considered the "gold standard". The sensitivity and specificity for the CT angiography regarding detection of significant coronary stenosis (ie more than 50 % lumen narrowing with the angiographic result as reference) and for revascularisation will be calculated separately.
- Change in quality of life and symptom score [ Time Frame: 6 months, 1 and 3 years ]Change from baseline in quality of life and symptoms as measured with SF-12, HADS og SEATTLE will be assessed both for patients with and without significant coronary pathology with postal questionnaires at 6 months, 1 and 3 years after the CT angiography
- Coronary calcium score impact on pretest coronary risk scoring and prognosis [ Time Frame: 24 hours, 5 and 10 years ]The change in pretest probability for detection of significant stenosis and revascularisation by calcium score will be calculated in addition to prediction of 5 and 10 year fatal and non fatal cardiovascular events.
- Vitamin D and other novel cardiovascular risk factors [ Time Frame: 24 hours, 5 and 10 years ]The association of vitamin D levels (25OHD) and Single Nucleotide Polymorphism (SNP) related to vitamin D and calcium metabolism to presence of coronary plaques and their calcium content will be analysed as well as risk of fatal and non fatal coronary events. When events are registered other new novel risk markers detected in the Tromso Study will be measured in a nested case control design.
- Real life radiation risk with new CT scanners and conventional invasive angiography [ Time Frame: 24 hours ]The radiation doses will be measured independent of supplier software for both procedures and compared. Impact of risk factors on radiation dosage and image quality will be determined.
|Study Start Date:||January 2012|
|Estimated Study Completion Date:||January 2022|
|Primary Completion Date:||December 2012 (Final data collection date for primary outcome measure)|
Non-invasive CT coronary angiography
This study is evaluating diagnostic accuracy of non-invasive CT coronary angiography with invasive coronary angiography.
Device: Cardiac Computer Tomography
Compare Cardiac CT with reference standard wich is conventional invasive coronary angiography.
Conventional invasive coronary angiography (CICA) is associated with few but serious complications. It is time consuming for the patient and incur costs to the health institution due to the post-procedure observation needed. Coronary computer tomography angiography (CCTA) is a good alternative to CICA to rule out coronary artery disease (CAD). Moderate to excellent sensitivity and negative predictive values have been reported with 64-slice CT angiography. The main ethical problem has been the radiation doses given to the patient during CT angiography which was high >10 millisievert(mSv). With 265 or higher slice CT machines and radiation dose reduction techniques, it is possible to evaluate coronary anatomy with radiation doses below 1 mSv. Heart rate reduction with B-blockers is in most cases not necessary with new generation CT machines but is recommended in guidelines.
800 patients already accepted for CICA based on clinical information will be scheduled to undergo CCTA prior to invasive coronary angiography. Coronary anatomy will be described according to American Heart Association (AHA) classification with 17 segment analysis. The main purpose of the study is to achieve high sensitivity and high negative predictive value with CT angiography. Radiation doses in relation to gender and body mass index (BMI) will be monitored. In addition we will measure coronary calcification (Agatson score) and look at any association to the Vitamin D and calcium metabolism. Patient reported quality of life evaluation with validated questionnaires and long term follow up (5 and 10 years) regarding clinical endpoints.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01476579
|University Hospital of North Norway|
|Tromsø, Norway, 9038|
|Principal Investigator:||AMJID IQBAL, MD, PhD||University Hospital of North Norway|